Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. Its products include human albumin, human immunoglobulin, human hepatitis B immunoglobulin, human rabies immunoglobulin, tetanus immunoglobulin and histamine human immunoglobulin. The company was founded on October 22, 2001 and is headquartered in Shenzhen, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company